Oriel Therapeutics has second a US patent covering its dry power inhaler packages, control systems and dispersion methods.
In all, the company is seeking 11 patents in the US and internationally. The company licensed the technology from the University of North Carolina at Chapel Hill.
“The patent covers the core of the Oriel technology including design of Oriel’s dry powder inhalers containing multi-dose dry powder packages that can individually be activated to vibrate upon exposure to a customized electrical input,” the company said in a statement. “The design allows for potentially quicker and easier administration of inhaled therapies to treat respiratory and pulmonary diseases.”
Timothy Crowder and Anthony Hickey, two of the company’s founders, invented the technology on which the patent is based.